Clinical Trial Update: ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS [Phase 4]

View source ↗

Summary

Clinical trial update on the ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 (SOP-DAPT-2) for patients with acute coronary syndrome; the Phase 4 study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction

Snippet

Sponsor: Kyoto University, Graduate School of Medicine | Conditions: Acute Coronary Syndrome, Acute Myocardial Infarction | Phase 4 | Status: ACTIVE_NOT_RECRUITING